ACG: Infliximab Trumps Azathioprine in Treatment of Crohn's Medical Video by Gastroenterology

ACG: Infliximab Trumps Azathioprine in Treatment of Crohn's

Gastroenterology

Currently 0.00/5
1
2
3
4
5

Rating: 0.0 out of 0 votes

Comments (0)

You need to have the Flash Player installed and a browser with JavaScript support.

Description

http://www.medpagetoday.com Gary Lichtenstein, M.D., director of the Inflammatory Bowel Disease Clinic at the University of Pennsylvania ORLANDO, Oct. 8 -- Treatment of mild to moderate Crohn's disease with infliximab (Remicade) allows more patients to achieve remission and mucosal healing than therapy together with the immunosuppressant azathioprine or without it, researchers said here.